FDA Approved: ULTOMIRIS — Original Application (Alexion Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Ultomiris (ravulizumab) through the original application for treatment of certain complement-mediated diseases, including paroxysmal nocturnal hemo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Hemolytic Uremic Syndrome
• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• ULTOMIRIS (ravulizumab)

Snippet

ORIG AP for ULTOMIRIS (RAVULIZUMAB)